278 related articles for article (PubMed ID: 18209144)
1. Dysregulation of Wnt pathway components in human salivary gland tumors.
Queimado L; Obeso D; Hatfield MD; Yang Y; Thompson DM; Reis AM
Arch Otolaryngol Head Neck Surg; 2008 Jan; 134(1):94-101. PubMed ID: 18209144
[TBL] [Abstract][Full Text] [Related]
2. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
3. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
4. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
[TBL] [Abstract][Full Text] [Related]
6. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer.
Wissmann C; Wild PJ; Kaiser S; Roepcke S; Stoehr R; Woenckhaus M; Kristiansen G; Hsieh JC; Hofstaedter F; Hartmann A; Knuechel R; Rosenthal A; Pilarsky C
J Pathol; 2003 Oct; 201(2):204-12. PubMed ID: 14517837
[TBL] [Abstract][Full Text] [Related]
7. Pleomorphic adenoma gene 1 is expressed in cultured benign and malignant salivary gland tumor cells.
Queimado L; Lopes C; Du F; Martins C; Bowcock AM; Soares J; Lovett M
Lab Invest; 1999 May; 79(5):583-9. PubMed ID: 10334569
[TBL] [Abstract][Full Text] [Related]
8. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A
Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505
[TBL] [Abstract][Full Text] [Related]
9. Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene.
Aström AK; Voz ML; Kas K; Röijer E; Wedell B; Mandahl N; Van de Ven W; Mark J; Stenman G
Cancer Res; 1999 Feb; 59(4):918-23. PubMed ID: 10029085
[TBL] [Abstract][Full Text] [Related]
10. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
11. [Study on the role of Wnt/beta-catenin signaling transduction pathway in hepatocellular carcinoma cell line HepG2 and L02 cell line].
Wang QM; Jia LQ; Zhou HY; Li YS
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct; 23(10):926-8. PubMed ID: 17908501
[TBL] [Abstract][Full Text] [Related]
12. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin stimulates Wnt inhibitory factor-1 expression through epigenetic regulations involving the transcription factor specificity protein 1.
Liu J; Lam JB; Chow KH; Xu A; Lam KS; Moon RT; Wang Y
Carcinogenesis; 2008 Nov; 29(11):2195-202. PubMed ID: 18701434
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
15. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
[TBL] [Abstract][Full Text] [Related]
16. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.
Chen G; Shukeir N; Potti A; Sircar K; Aprikian A; Goltzman D; Rabbani SA
Cancer; 2004 Sep; 101(6):1345-56. PubMed ID: 15316903
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
Nakashiro K; Kawamata H; Hino S; Uchida D; Miwa Y; Hamano H; Omotehara F; Yoshida H; Sato M
Cancer Res; 1998 Feb; 58(3):549-55. PubMed ID: 9458104
[TBL] [Abstract][Full Text] [Related]
19. Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic mice.
Zhao X; Ren W; Yang W; Wang Y; Kong H; Wang L; Yan L; Xu G; Fei J; Fu J; Zhang C; Wang Z
Int J Cancer; 2006 Feb; 118(3):643-8. PubMed ID: 16108035
[TBL] [Abstract][Full Text] [Related]
20. Target genes of the WNT/beta-catenin pathway in Wilms tumors.
Zirn B; Samans B; Wittmann S; Pietsch T; Leuschner I; Graf N; Gessler M
Genes Chromosomes Cancer; 2006 Jun; 45(6):565-74. PubMed ID: 16575872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
